"I Am a Scientist, Not a Salesperson": The Identity Crisis Keeping Research Out of the Room
The most persistent barrier between university research and investment capital is not technical, financial, or legal. It is a deeply held belief — formed over years of academic socialisation — that seeking money for one's work is somehow beneath the work itself.
A professor of structural biology at a Finnish university had, by any reasonable measure, everything an investor could want. A platform technology with three independent validation studies. A clear application in oncology diagnostics with an identified clinical partner. A patent portfolio that had survived Freedom to Operate analysis. A market that analysts sized at several billion euros within a decade. What she did not have was the ability to walk into a room of investors and ask for money. "Every time I tried to prepare for it," she said, "I felt like I was about to do something dishonest. Like I was selling something. And I am not a salesperson. I am a scientist." She did not pursue the investment. The technology has not progressed.
Her hesitation is not a personality quirk. It is a trained response — the product of years spent inside an institutional culture that has elevated disinterested inquiry as its highest value, and treated the active pursuit of commercial reward with a suspicion that goes back, in some form, to the very origins of organised science.
The roots of the discomfort are genuinely old. The ideal of the scientist as a disinterested seeker of truth — motivated by curiosity rather than gain, speaking to posterity rather than to markets — was already well-formed by the time Robert Boyle articulated it in the seventeenth century, and it hardened into institutional norm through the founding charters of the Royal Society and its continental equivalents. Commerce was not the enemy of science in this conception, but it was decidedly separate from it. The man of science who sought to profit from his discoveries was, in the social code of early modern natural philosophy, doing something slightly embarrassing.
This norm persisted, in evolving forms, through the professionalisation of science in the nineteenth century and the construction of the research university in the twentieth. The culture of the academic department — with its seminars, its peer review, its careful gradations of intellectual seniority based on the rigour and originality of published work — reinforced a particular self-image: the scientist as someone whose authority came precisely from being uncorrupted by external interest. Funding was sought from disinterested patrons — first aristocratic, then governmental — not negotiated in rooms with people who expected a return.
The commercialisation mandates of the 1980s and 1990s arrived into this culture without dismantling any of it. Universities were told to generate spinouts and licences. Researchers were told, in effect, to become entrepreneurs. The institutional identity that had been constructed over three centuries was not updated to accommodate the instruction. It simply absorbed it as a contradiction — one more thing the modern academic was supposed to do, sitting uncomfortably alongside everything they had been trained to be.
A 2020 study in Research Policy surveyed over 2,400 academic researchers across seven European countries and found that "identity threat" — the perception that commercial engagement conflicted with their self-image as a scientist — was the single most commonly cited reason for not pursuing commercialisation, outranking lack of time, lack of funding, and lack of institutional support. A separate US study found that researchers who described themselves as having a strong "academic scientist" identity were 40% less likely to disclose inventions to their TTOs than those with more hybrid identities, regardless of the commercial potential of their work. The barrier, in both cases, was not external. It was internal — and it had been placed there by the culture itself.
The specific fear of being perceived as a salesperson is worth examining carefully, because it contains a genuine misunderstanding about what pitching is. Selling, in the pejorative sense that most researchers fear, involves persuading someone to acquire something they do not need, or misrepresenting the thing on offer. Pitching to investors involves presenting evidence of a real opportunity to people whose professional purpose is to find and fund exactly such opportunities. These are not the same activity. The researcher who conflates them is not being modest. They are applying the wrong category — and paying for it with every investment conversation they do not have.
"There is a word we use for a scientist who presents their findings clearly, argues for their significance, and asks a funding body to support the next stage of the work. We call them a good grant writer. I do not understand why the same activity, directed at a different audience, suddenly becomes something to be ashamed of."
— Science commercialisation advisor, LeuvenThe practical consequences of this identity barrier are specific and well-documented. Researchers who experience identity discomfort around commercial engagement consistently delay disclosure of inventions, avoid investor introductions offered by their TTOs, withdraw from pitch competitions after one unsuccessful attempt, and systematically understate the significance and market potential of their work when they do present — a kind of pre-emptive self-deprecation that reads, to investors, as lack of conviction in the opportunity.
The withdrawal pattern is particularly costly. Unlike a failed grant application, which a researcher will almost invariably revise and resubmit, a failed investor pitch tends to confirm the existing belief that the commercial world is not a place where they belong. The feedback loop runs in the wrong direction: each unsuccessful attempt reinforces the identity conclusion rather than generating the kind of iterative learning that would, over time, produce a different outcome.
"I went to one pitch event, was rejected, and told myself it proved I wasn't cut out for it. I now think it proved I needed practice. Those are very different conclusions. I reached the wrong one for six years."
There is also a generational dimension that is rarely discussed. Senior researchers — full professors, principal investigators with decades of reputation carefully constructed within academic norms — have the most to lose, by their own calculus, from being seen as commercially motivated. They also tend to have the most commercially valuable work. The combination produces a particular kind of paralysis: the researcher most capable of attracting significant investment is often the one most resistant to attempting it, because the professional identity they are protecting is the one they have spent a career building.
What changes this is not exhortation, and it is not a one-day workshop on entrepreneurial mindset. Both of those interventions exist in abundance at most research universities. Neither has meaningfully shifted the underlying dynamic, because neither addresses the specific mechanism producing the discomfort: the researcher standing in a room alone, without the vocabulary, the structure, or the practiced confidence to carry twenty minutes of their own data to a conclusion that asks for something.
What works — and what the evidence from accelerator programmes and deep-tech pitch training consistently supports — is iterative, personalised coaching built around the researcher's own work and their own voice. Not a generic pitch formula imposed from outside, but a process that starts with what the researcher already knows how to do — present data, defend a methodology, make a case — and builds from there toward the specific competencies the investment room requires. Structuring the narrative around market evidence rather than experimental sequence. Practising the opening two minutes until the problem statement lands without hedging. Learning to answer the questions investors actually ask, rather than the ones a peer reviewer would.
After that process, the researcher who walks into the room is still a scientist. They have not been asked to become a different person, adopt a different set of values, or pretend that their careful epistemic habits are something other than an asset. They have simply learned that advocacy for genuinely important work — grounded in data, framed for a specific audience, delivered with the confidence that comes from preparation — is not a compromise of who they are. It is, in fact, one of the most consequential things that who they are can do. Even the most reserved professor, speaking from twenty minutes of structured preparation built on their own results and supported by rigorous market intelligence, can hold a room. They always could. They simply needed someone to show them how.